Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Male Breast Cancer Market, by Type
6.1 Introduction
6.2 Ductal Carcinoma in Situ
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.3 Pagetโs Disease of the Nipple
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.4 Inflammatory Breast Cancer
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.5 Infiltrating Ductal Carcinoma
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.6 Others
Chapter 7. Global Male Breast Cancer Market, by Diagnosis
7.1 Introduction
7.2 Mammography
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.3 Biopsy
7.3.1 Fine-Needle Aspiration Biopsy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.3.2 Core Biopsy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.3.3 Excisional Biopsy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.4 PET Scan
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.5 CT Scan
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.6 MRI Scan
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.7 Other Tests
Chapter 8. Global Male Breast Cancer Market, by Treatment
8.1 Introduction
8.2 Local Treatments
8.2.1 Surgery
8.2.1.1 Mastectomy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.1.2 Breast-Conserving Surgery (BCS)
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.1.3 Lymph Nodes Biopsy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.2.2 Radiation Therapy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3 Systemic Treatments
8.3.1 Chemotherapy
8.3.1.1 Adjuvant Therapy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3.1.2 Neoadjuvant Therapy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3.2 Hormone Therapy
8.3.2.1 Using Drugs
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3.2.2 Orchiectomy (Castration)
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3.3 Targeted Therapy
8.3.3.1 For HER2 Positive Breast Cancer
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3.3.2 For Hormone Receptor Positive Breast Cancer
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3.3.3 For Cancer with BRCA Mutations
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
Chapter 9. Global Male Breast Cancer Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 Achieve Life Sciences, Inc.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Pfizer Inc.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Eli Lilly and Company
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Bristol-Myers Squibb Company
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 F. Hoffman-La Roche Ltd.
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Sanofi
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Novartis AG
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 BioNumerik Pharmaceuticals Inc.
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Seattle Genetics, Inc.
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 GlaxoSmithKline Plc.
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Sun Pharmaceutical Industries Ltd.
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 AstraZeneca
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Accord Healthcare
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Bayer AG
11.15.1 Overview
11.15.2 Product Overview
11.15.3 Financials
11.15.4 Key Developments
11.15.5 SWOT Analysis
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEOโs Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Male Breast Cancer Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Male Breast Cancer Market Synopsis, 2020โ2027
Table 2 Global Male Breast Cancer Market Estimates and Forecast, 2020โ2027 (USD Million)
Table 3 Global Male Breast Cancer Market, by Region, 2020โ2027 (USD Million)
Table 4 Global Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 5 Global Male Breast Cancer Market, by Diagnosis, 2020โ2027(USD Million)
Table 6 Global Male Breast Cancer Market, by Treatment, 2020โ2027 (USD Million)
Table 7 North America: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 8 North America: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 9 North America: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD Million)
Table 10 US: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 11 US: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 12 US: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD Million)
Table 13 Canada: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 14 Canada: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 15 Canada: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD Million)
Table 16 South America: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 17 South America: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 18 South America: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD Million)
Table 19 Europe: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 20 Europe: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 21 Europe: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD Million)
Table 22 Western Europe: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 23 Western Europe: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 24 Western Europe: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD
Million)
Table 25 Eastern Europe: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 26 Eastern Europe: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 27 Eastern Europe: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD Million)
Table 28 Asia-Pacific: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 29 Asia-Pacific: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 30 Asia-Pacific: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD Million)
Table 31 Middle East & Africa: Male Breast Cancer Market, by Type, 2020โ2027 (USD Million)
Table 32 Middle East & Africa: Male Breast Cancer Market, by Diagnosis, 2020โ2027 (USD Million)
Table 33 Middle East & Africa: Male Breast Cancer Market, by Treatment, 2020โ2027 (USD
Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Male Breast Cancer Market
Figure 3 Segmentation Market Dynamics for Global Male Breast Cancer Market
Figure 4 Global Male Breast Cancer Market Share, by Type, 2020
Figure 5 Global Male Breast Cancer Market Share, by Diagnosis, 2020
Figure 6 Global Male Breast Cancer Market Share, by Treatment, 2020
Figure 7 Global Male Breast Cancer Market Share, by Region, 2020
Figure 8 North America: Male Breast Cancer Market Share, by Country, 2020
Figure 9 Europe: Male Breast Cancer Market Share, by Country, 2020
Figure 10 Asia-Pacific: Male Breast Cancer Market Share, by Country, 2020
Figure 11 Middle East & Africa: Male Breast Cancer Market Share, by Country, 2020
Figure 12 Global Male Breast Cancer Market: Company Share Analysis, 2020 (%)
Figure 13 Achieve Life Sciences, Inc.: Key Financials
Figure 14 Achieve Life Sciences, Inc.: Segmental Revenue
Figure 15 Achieve Life Sciences, Inc.: Geographical Revenue
Figure 16 Pfizer Inc.: Key Financials
Figure 17 Pfizer Inc.: Segmental Revenue
Figure 18 Pfizer Inc.: Geographical Revenue
Figure 19 Eli Lily and Company: Key Financials
Figure 20 Eli Lily and Company: Segmental Revenue
Figure 21 Eli Lily and Company: Geographical Revenue
Figure 22 Bristol-Myers Squibb Company: Key Financials
Figure 23 Bristol-Myers Squibb Company: Segmental Revenue
Figure 24 Bristol-Myers Squibb Company: Geographical Revenue
Figure 25 F. Hoffman-La Roche Ltd.: Key Financials
Figure 26 F. Hoffman-La Roche Ltd.: Segmental Revenue
Figure 27 F. Hoffman-La Roche Ltd.: Geographical Revenue
Figure 28 Sanofi: Key Financials
Figure 29 Sanofi: Segmental Revenue
Figure 30 Sanofi: Geographical Revenue
Figure 31 Novartis AG: Key Financials
Figure 32 Novartis AG: Segmental Revenue
Figure 33 Novartis AG: Geographical Revenue
Figure 34 BioNumerik Pharmaceuticals Inc.: Financials
Figure 35 BioNumerik Pharmaceuticals Inc.: Segmental Revenue
Figure 36 BioNumerik Pharmaceuticals Inc.: Geographical Revenue
Figure 37 Seattle Genetics, Inc.: Key Financials
Figure 38 Seattle Genetics, Inc.: Segmental Revenue
Figure 39 Seattle Genetics, Inc.: Geographical Revenue
Figure 40 GlaxoSmithKline plc: Key Financials
Figure 41 GlaxoSmithKline plc: Segmental Revenue
Figure 42 GlaxoSmithKline plc: Geographical Revenue
Figure 43 Teva Pharmaceutical Industries Ltd.: Key Financials
Figure 44 Teva Pharmaceutical Industries Ltd.: Segmental Revenue
Figure 45 Teva Pharmaceutical Industries Ltd.: Geographical Revenue
Figure 46 Sun Pharmaceutical Industries Ltd.: Key Financials
Figure 47 Sun Pharmaceutical Industries Ltd.: Segmental Revenue
Figure 48 Sun Pharmaceutical Industries Ltd.: Geographical Revenue
Figure 49 AstraZeneca: Key Financials
Figure 50 AstraZeneca: Segmental Revenue
Figure 51 AstraZeneca: Geographical Revenue
Figure 52 Accord Healthcare: Key Financials
Figure 53 Accord Healthcare: Segmental Revenue
Figure 54 Accord Healthcare: Geographical Revenue
Figure 55 Bayer AG: Key Financials
Figure 56 Bayer AG: Segmental Revenue
Figure 57 Bayer AG: Geographical Revenue
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
ยฉ 2024 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)
